These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8790831)

  • 1. Cellular sociology of proliferating tumor cells in invasive ductal breast cancer.
    Haroske G; Dimmer V; Steindorf D; Schilling U; Theissig F; Kunze KD
    Anal Quant Cytol Histol; 1996 Jun; 18(3):191-8. PubMed ID: 8790831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma].
    Harbeck N; Dettmar P; Thomssen Ch; Pache L; Ziffer P; Fizi K; Jänicke F; Nathrath W; Schmitt M; Graeff H
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():142-7. PubMed ID: 8672914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
    Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T
    Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative activity in invasive breast carcinoma: a comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to image analytic, flow cytometric and histologic parameters.
    Ostrowski ML; Pindur J; Laucirica R; Chakraborty S; Ramzy I
    Acta Cytol; 2001; 45(6):965-72. PubMed ID: 11726126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
    MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
    Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of different methods for determination of proliferative activity of breast carcinomas].
    Mink D; Villena-Heinsen C; Tossounidis I; Schmidt W
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():53-6. PubMed ID: 8672927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces.
    Lloyd MC; Cunningham JJ; Bui MM; Gillies RJ; Brown JS; Gatenby RA
    Cancer Res; 2016 Jun; 76(11):3136-44. PubMed ID: 27009166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB1-determined proliferative activity in intraductal components and prognosis of invasive ductal breast carcinoma.
    Imamura H; Haga S; Shimizu T; Watanabe O; Kajiwara T; Aiba M
    Jpn J Cancer Res; 1997 Oct; 88(10):1017-23. PubMed ID: 9414665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic grading of invasive breast carcinoma. Correlation with clinicopathologic variables and predictive value of nodal metastasis.
    Taniguchi E; Yang Q; Tang W; Nakamura Y; Shan L; Nakamura M; Sato M; Mori I; Sakurai T; Kakudo K
    Acta Cytol; 2000; 44(4):587-91. PubMed ID: 10934952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
    Vartanian RK; Weidner N
    Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
    Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
    Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.